Skin Test Evaluation of a Novel Peptide Carrier-based Vaccine, BM32, in Grass Pollen-allergic Patients

Overview

Journal J Allergy Clin Immunol

Specialty Allergy & Immunology

Date 2015 Jun 7

PMID 26048664

Citations 23

Authors

Verena Niederberger

Katharina Marth

Julia Eckl-Dorna

Margarete Focke-Tejkl

Milena Weber

Wolfgang Hemmer

Uwe Berger

Angela Neubauer

Frank Stolz

Rainer Henning

Rudolf Valenta

Affiliations

Soon will be listed here.

Citing Articles

IgG in the control of FcεRI activation: a battle on multiple fronts.

Storni F, Vogel M, Bachmann M, Engeroff P Front Immunol. 2024; 14:1339171.

PMID: 38274816 PMC: 10808611. DOI: 10.3389/fimmu.2023.1339171.

Peptide immunotherapy for aeroallergens.

Midoro-Horiuti T, Schein C Allergy Asthma Proc. 2023; 44(4):237-243.

PMID: 37480199 PMC: 10362967. DOI: 10.2500/aap.2023.44.230028.

Preventive Allergen-Specific Vaccination Against Allergy: Mission Possible?.

Tulaeva I, Kratzer B, Campana R, Curin M, van Hage M, Karsonova A Front Immunol. 2020; 11:1368.

PMID: 32733455 PMC: 7358538. DOI: 10.3389/fimmu.2020.01368.

Past, present, and future of allergen immunotherapy vaccines.

Dorofeeva Y, Shilovskiy I, Tulaeva I, Focke-Tejkl M, Flicker S, Kudlay D Allergy. 2020; 76(1):131-149.

PMID: 32249442 PMC: 7818275. DOI: 10.1111/all.14300.

Mechanisms of allergen-specific immunotherapy for allergic rhinitis and food allergies.

Lam H, Tergaonkar V, Ahn K Biosci Rep. 2020; 40(4).

PMID: 32186703 PMC: 7109000. DOI: 10.1042/BSR20200256.

References

Winther L, Malling H, Mosbech H . Allergen-specific immunotherapy in birch- and grass-pollen-allergic rhinitis. II. Side-effects. Allergy. 2000; 55(9):827-35. DOI: 10.1034/j.1398-9995.2000.00368.x. View

Niederberger V, Horak F, Vrtala S, Spitzauer S, Krauth M, Valent P . Vaccination with genetically engineered allergens prevents progression of allergic disease. Proc Natl Acad Sci U S A. 2004; 101 Suppl 2:14677-82. PMC: 521981. DOI: 10.1073/pnas.0404735101. View

Turjanmaa K, Darsow U, Niggemann B, Rance F, Vanto T, Werfel T . EAACI/GA2LEN position paper: present status of the atopy patch test. Allergy. 2006; 61(12):1377-84. DOI: 10.1111/j.1398-9995.2006.01136.x. View

Larche M . Update on the current status of peptide immunotherapy. J Allergy Clin Immunol. 2007; 119(4):906-9. DOI: 10.1016/j.jaci.2007.02.015. View

Jacobsen L, Niggemann B, Dreborg S, Ferdousi H, Halken S, Host A . Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study. Allergy. 2007; 62(8):943-8. DOI: 10.1111/j.1398-9995.2007.01451.x. View

Pree I, Reisinger J, Focke M, Vrtala S, Pauli G, van Hage M . Analysis of epitope-specific immune responses induced by vaccination with structurally folded and unfolded recombinant Bet v 1 allergen derivatives in man. J Immunol. 2007; 179(8):5309-16. DOI: 10.4049/jimmunol.179.8.5309. View

Focke M, Marth K, Flicker S, Valenta R . Heterogeneity of commercial timothy grass pollen extracts. Clin Exp Allergy. 2008; 38(8):1400-8. DOI: 10.1111/j.1365-2222.2008.03031.x. View

Valenta R, Campana R, Marth K, van Hage M . Allergen-specific immunotherapy: from therapeutic vaccines to prophylactic approaches. J Intern Med. 2012; 272(2):144-57. PMC: 4573524. DOI: 10.1111/j.1365-2796.2012.02556.x. View

Pellaton C, Perrin Y, Boudousquie C, Barbier N, Wassenberg J, Corradin G . Novel birch pollen specific immunotherapy formulation based on contiguous overlapping peptides. Clin Transl Allergy. 2013; 3(1):17. PMC: 3672070. DOI: 10.1186/2045-7022-3-17. View

10.

Focke-Tejkl M, Weber M, Niespodziana K, Neubauer A, Huber H, Henning R . Development and characterization of a recombinant, hypoallergenic, peptide-based vaccine for grass pollen allergy. J Allergy Clin Immunol. 2014; 135(5):1207-7.e1-11. PMC: 4418753. DOI: 10.1016/j.jaci.2014.09.012. View